Issue 13 - Mar 31, 2017
  • Conversation with the Cancer Letter

    Amy Abernethy: I want health IT companies to have an honest conversation about data sharing

    It’s fair to say that eight years ago, when the Obama administration infused the economy with $800 billion in stimulus funding, policymakers likely did not expect the health information technology industry to evolve into fiefdoms guarded by legions of lawyers and walls of proprietary code.

  • Genentech’s rituximab SC received unanimous ODAC approval recommendation

    The FDA Oncologic Drugs Advisory Committee March 29 unanimously recommended approval of a lymphoma treatment, to be administered via subcutaneous injection.

  • In Brief

    • Carlo Croce to receive 2017 AACR Margaret Foti Award for leadership, achievements in research
    • Roger Lo to receive AACR-Waun Ki Hong award for outstanding achievement in cancer research
    • Bezos family donates $35M to Fred Hutchinson
    • Cancer death rates continue to decrease
    • NCCN publishes Radiation Therapy Compendium
    • NCCN Foundation awards grants to four young investigators
    • Friends launches ProgressForPatients.org
    • Health coalition forms National Lung Cancer Roundtable
    • Columbia, New York-Presbyterian, FNIH enter research collaboration
    • The Mikey Czech Foundation Contributes $1 Million To DIPG Research at Dana-Farber
    • Jeffrey Ravetch gets Ross Prize in Molecular Medicine
    • Alan Bernstein awarded Friesen prize
  • Drugs and Targets

    • FDA approves AstraZeneca’s Tagrisso for EGFR mutation-positive NSCLC
    • FDA approves niraparib for epithelial ovarian, fallopian tube, or primary peritoneal cancer
    • Gamida Cell receives EMA orphan drug designation for NiCord
    • Cota, Novartis form collaboration to advance real-world evidence in breast cancer therapies
    • Novartis CAR-T cell therapy for pediatric r/r B-cell ALL gets FDA Priority Review
    • BMS, Foundation Medicine form collaboration to identify predictive biomarkers across tumor types, immunotherapy agents
    • AbbVie, M2Gen announce collaboration for the ORIEN Avatar Research Program
Issue 12 - Mar 24, 2017
Issue 11 - Mar 17, 2017